How is the Bright Minds Biosciences Inc today?

The Bright Minds Biosciences Inc today is trading in the down by -0.69% at 30.22.

What is Bright Minds Biosciences Inc Annual Net Profit?

Bright Minds Biosciences Inc Annual Net Profit rose 61.99% in the last year to $2.8 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Bright Minds Biosciences Inc Price to Earning Ratio?

Bright Minds Biosciences Inc Price to Earning Ratio is -277.74, which is negative.

What is Bright Minds Biosciences Inc Stock Price?

Bright Minds Biosciences Inc Stock Price rose 2,377.05% and outperformed its sector by 2,365.51% in the past year.

What is Bright Minds Biosciences Inc Quarterly Net profit?

Bright Minds Biosciences Inc Quarterly Net profit rose 102.95% YoY to $0.05 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Bright Minds Biosciences Inc Debt to Equity Ratio?

Bright Minds Biosciences Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Bright Minds Biosciences Inc Return on Equity(ROE)?

Bright Minds Biosciences Inc Return on Equity(ROE) for the last financial year was -46.18%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bright Minds Biosciences Inc Mutual Fund Holding?

Bright Minds Biosciences Inc Mutual Fund Holding increased by 0.07% in the last quarter to 0.23.

What is Bright Minds Biosciences Inc Institutional Holding?

Bright Minds Biosciences Inc Institutional Holding increased by 10.19% in the last quarter to 79.59.

Bright Minds Biosciences Inc XNAS: DRUG

Bright Minds Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Bright Minds Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Bright Minds Biosciences Inc
Rating: 0.94666675
Author: Trendlyne DVM scores

about

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities ...

30.22 -0.21 (-0.69%)

61.76% Fall from 52W High

36,638 XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

2.7 / 100

Technically Neutral

35.2 / 100

No estimates available

Bright Minds Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bright Minds Biosciences Inc FAQ

How is Bright Minds Biosciences Inc today?

Bright Minds Biosciences Inc today is trading in the red, and is down by -0.69% at 30.22.

How has Bright Minds Biosciences Inc performed historically?

Bright Minds Biosciences Inc is currently trading down -0.69% on an intraday basis. In the past week the stock fell -4.67%. stock has been down -16.03% in the past quarter and rose 2377.05% in the past year. You can view this in the overview section.